Kyndryl Stock Drops Amid Morgan Stanley's Price Target Cut and Guggenheim's Rating Downgrade

Kyndryl shares fell 5.1% after Morgan Stanley slashed its price target to $13.00 from $28.00, and Guggenheim downgraded its rating from Buy to Neutral due to key management departures and misstated financial statements. The stock closed at $12.39, down 4.4% from the previous close. Despite volatility, the market considers this news meaningful but not fundamental to the business.